John Hester
Stock Analyst at Bell Potter
(3.74)
# 2,045
Out of 5,070 analysts
232
Total ratings
43.1%
Success rate
6.2%
Average return
Main Sectors:
Stocks Rated by John Hester
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: SIG Sigma Healthcare Limited | Downgraded: Hold | $3.00 | $2.75 | +9.09% | 7 | Oct 19, 2026 | |
| ASX: MSB Mesoblast Limited | Reiterated: Buy | $4.45 → $4.40 | $1.86 | +136.56% | 24 | Oct 18, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Reiterated: Buy | $1.09 | $0.51 | +113.73% | 8 | Oct 6, 2026 | |
| ASX: EIQ Echo IQ Limited | Reiterated: Sell | $0.30 | $0.42 | -27.71% | 5 | Sep 22, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $19.00 | $14.52 | +30.85% | 35 | Sep 21, 2026 | |
| ASX: 4DX 4DMedical Limited | Reiterated: Buy | $6.00 | $3.84 | +56.25% | 14 | Aug 30, 2026 | |
| ASX: PNV PolyNovo Limited | Upgraded: Buy | $1.00 → $1.22 | $0.90 | +35.56% | 13 | Aug 28, 2026 | |
| ASX: PGC Paragon Care Limited | Reiterated: Hold | $0.17 → $0.16 | $0.15 | +6.67% | 18 | Aug 27, 2026 | |
| ASX: NAN Nanosonics Limited | Reiterated: Hold | $3.60 → $3.20 | $3.03 | +5.61% | 17 | Aug 26, 2026 | |
| ASX: CYC Cyclopharm Limited | Reiterated: Buy | $1.00 | $0.37 | +170.27% | 15 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $226.00 | $184.83 | +22.27% | 16 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.24 → $0.22 | $0.11 | +100.00% | 5 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13.00 | $9.00 | +44.44% | 5 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6.50 → $6.40 | $1.78 | +259.55% | 20 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.45 → $0.42 | $0.25 | +71.43% | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.25 | $0.04 | +575.68% | 7 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.05 → $0.06 | $0.00 | +1,400.00% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.18 → $0.15 | $0.02 | n/a | 2 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.01 | $0.00 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.98 → $3.93 | $4.58 | n/a | 3 | Nov 25, 2022 |
Sigma Healthcare Limited
Oct 19, 2026
Downgraded: Hold
Price Target: $3.00
Current: $2.75
Upside: +9.09%
Mesoblast Limited
Oct 18, 2026
Reiterated: Buy
Price Target: $4.45 → $4.40
Current: $1.86
Upside: +136.56%
Aroa Biosurgery Limited
Oct 6, 2026
Reiterated: Buy
Price Target: $1.09
Current: $0.51
Upside: +113.73%
Echo IQ Limited
Sep 22, 2026
Reiterated: Sell
Price Target: $0.30
Current: $0.42
Upside: -27.71%
Telix Pharmaceuticals Limited
Sep 21, 2026
Reiterated: Buy
Price Target: $19.00
Current: $14.52
Upside: +30.85%
4DMedical Limited
Aug 30, 2026
Reiterated: Buy
Price Target: $6.00
Current: $3.84
Upside: +56.25%
PolyNovo Limited
Aug 28, 2026
Upgraded: Buy
Price Target: $1.00 → $1.22
Current: $0.90
Upside: +35.56%
Paragon Care Limited
Aug 27, 2026
Reiterated: Hold
Price Target: $0.17 → $0.16
Current: $0.15
Upside: +6.67%
Nanosonics Limited
Aug 26, 2026
Reiterated: Hold
Price Target: $3.60 → $3.20
Current: $3.03
Upside: +5.61%
Cyclopharm Limited
Aug 25, 2026
Reiterated: Buy
Price Target: $1.00
Current: $0.37
Upside: +170.27%
Aug 19, 2026
Reiterated: Buy
Price Target: $226.00
Current: $184.83
Upside: +22.27%
Aug 18, 2026
Reiterated: Buy
Price Target: $0.24 → $0.22
Current: $0.11
Upside: +100.00%
Aug 12, 2026
Downgraded: Hold
Price Target: $13.00
Current: $9.00
Upside: +44.44%
Aug 10, 2026
Reiterated: Buy
Price Target: $6.50 → $6.40
Current: $1.78
Upside: +259.55%
Aug 3, 2026
Reiterated: Buy
Price Target: $0.45 → $0.42
Current: $0.25
Upside: +71.43%
May 28, 2026
Reiterated: Buy
Price Target: $0.25
Current: $0.04
Upside: +575.68%
Dec 17, 2025
Reiterated: Buy
Price Target: $0.05 → $0.06
Current: $0.00
Upside: +1,400.00%
Sep 3, 2025
Downgraded: Hold
Price Target: $0.18 → $0.15
Current: $0.02
Upside: n/a
Dec 19, 2024
Downgraded: Hold
Price Target: $0.01
Current: $0.00
Upside: n/a
Nov 25, 2022
Reiterated: Hold
Price Target: $4.98 → $3.93
Current: $4.58
Upside: n/a